Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease
2008 · Proceedings of the National Academy of Sciences · 206 citations
https://doi.org/10.1073/pnas.0800712105
D
David P. Smith
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
177
Papers
6.4K
Citations
40
h-index
82
i10-index
David P. Smith is an academic researcher from Sheffield Hallam University. The author has contributed to research in topics: Alzheimer's disease research and treatments & Mass Spectrometry Techniques and Applications & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 40, co-authored 151 publications.
ORCID: 0000-0001-5177-8574Papers by this author
worksPost translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
2017 · Molecular Neurodegeneration · 72 citations
https://doi.org/10.1186/s13024-017-0186-8
Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease
2020 · Archives of Toxicology · 11 citations
https://doi.org/10.1007/s00204-020-02672-y
How Students’ Inspirations and Aspirations Impact Motivation and Engagement in the First Year of Study
2022 · Education Sciences · 9 citations
https://doi.org/10.3390/educsci12120885
Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7791314
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat